Table 4B.
Blastocyst rate and embryo quality according to morphological criteria described previously (Staicu et al., 2021) of control vs. 10% HUF embryos of each patient who accepted to participate in the proof-of-concept NCT03436758QC and fulfilled all the inclusion criteria, namely, the retrieval of at least eight metaphase II oocytes, and transfer of their embryos.
| PATIENT | OOCYTES | Exp. Group | MII | CLEAVAGE (%, N) | BLASTOCYST RATE (%, N) | Morphological scoring at day 5/6 of embryo culture |
|---|---|---|---|---|---|---|
| 1 | 13 | HUF | 6 | 67 (N = 4) | 100 (N = 4) | 2B /2C |
| Ctrl | 6 | 67 (N = 4) | 100 (N = 4) | 2A /2B | ||
| 2 | 10 | HUF | 5 | 40 (N = 2) | 50 (N = 1) | 1B |
| Ctrl | 5 | 80 (N = 4) | 25 (N = 1) | D | ||
| 3 | 17 | HUF | 8 | 75 (N = 6) | 33 (N = 2) | 1A/1C |
| Ctrl | 7 | 100 (N = 7) | 29 (N = 2) | 1C /1C | ||
| 4 | 17 | HUF | 8 | 75 (N = 6) | 33 (N = 2) | 1B/1C |
| Ctrl | 7 | 86 (N = 6) | 83 (N = 5) | 2A/3B | ||
| 5 | 25 | HUF | 7 | 86 (N = 6) | 17 (N = 1) | 1B |
| Ctrl | 7 | 86 (N = 6) | 17 (N = 1) | 1C | ||
| 6 | 19 | HUF | 8 | 75 (N = 6) | 17 (N = 1) | 1A |
| Ctrl | 7 | 100 (N = 7) | 43 (N = 3) | 2A/1C |